REVLIMID for Myelodysplastic syndrome: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 835 adverse event reports in the FDA FAERS database where REVLIMID was used for Myelodysplastic syndrome.
Most Reported Side Effects for REVLIMID
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pneumonia | 652 | 7.3% | 85 | 589 |
| Plasma cell myeloma | 632 | 7.1% | 241 | 184 |
| Death | 565 | 6.4% | 564 | 51 |
| Diarrhoea | 508 | 5.7% | 20 | 207 |
| Thrombosis | 484 | 5.5% | 4 | 165 |
| Fatigue | 448 | 5.1% | 17 | 149 |
| Platelet count decreased | 362 | 4.1% | 9 | 112 |
| Full blood count decreased | 352 | 4.0% | 6 | 172 |
| Deep vein thrombosis | 332 | 3.7% | 6 | 154 |
| Pancytopenia | 319 | 3.6% | 20 | 91 |
| Rash | 310 | 3.5% | 11 | 88 |
| Anaemia | 286 | 3.2% | 28 | 145 |
| White blood cell count decreased | 284 | 3.2% | 4 | 102 |
| Neutropenia | 253 | 2.9% | 33 | 93 |
| Asthenia | 239 | 2.7% | 17 | 136 |
Other Indications for REVLIMID
Plasma cell myeloma (7,122)
Chronic lymphocytic leukaemia (121)
Lymphoma (121)
Product used for unknown indication (90)
Mantle cell lymphoma (76)
5q minus syndrome (72)
Acute myeloid leukaemia (56)
Amyloidosis (56)
Myelofibrosis (52)
B-cell lymphoma (41)
Other Drugs Used for Myelodysplastic syndrome
LENALIDOMIDE (14,132)
AZACITIDINE (5,741)
VENETOCLAX (2,508)
DEFERASIROX (1,445)
DARBEPOETIN ALFA (1,164)
RUXOLITINIB (886)
CEDAZURIDINE\DECITABINE (770)
LUSPATERCEPT-AAMT (609)
DECITABINE (429)
CYTARABINE (386)